Heartflow, Inc. (NASDAQ:HTFL) Given Consensus Recommendation of “Moderate Buy” by Analysts

Heartflow, Inc. (NASDAQ:HTFL) has received a consensus rating of “Moderate Buy” from the ten ratings firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $37.00.

Several equities analysts recently weighed in on HTFL shares. Stifel Nicolaus set a $40.00 price target on shares of Heartflow in a research report on Wednesday, July 15th. Wells Fargo & Company boosted their target price on shares of Heartflow from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Canaccord Genuity Group reduced their target price on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research report on Friday, May 15th. Freedom Capital upgraded shares of Heartflow to a “strong-buy” rating in a research note on Tuesday, June 30th. Finally, Weiss Ratings cut shares of Heartflow from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, July 8th.

Insider Buying and Selling at Heartflow

In related news, CEO John C.M. Farquhar sold 22,562 shares of Heartflow stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $27.75, for a total value of $626,095.50. Following the completion of the sale, the chief executive officer owned 435,373 shares of the company’s stock, valued at approximately $12,081,600.75. This trade represents a 4.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the business’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $28.34, for a total value of $261,266.46. Following the completion of the sale, the insider owned 78,731 shares in the company, valued at $2,231,236.54. This represents a 10.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 115,805 shares of company stock worth $3,548,884. Corporate insiders own 7.70% of the company’s stock.

Hedge Funds Weigh In On Heartflow

Large investors have recently modified their holdings of the business. TrueMark Investments LLC boosted its holdings in Heartflow by 1.4% in the 1st quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock worth $654,000 after buying an additional 379 shares during the period. Caitong International Asset Management Co. Ltd bought a new stake in Heartflow during the 4th quarter valued at $27,000. Strs Ohio lifted its position in shares of Heartflow by 35.3% during the first quarter. Strs Ohio now owns 4,600 shares of the company’s stock worth $112,000 after acquiring an additional 1,200 shares in the last quarter. Russell Investments Group Ltd. purchased a new stake in shares of Heartflow during the fourth quarter worth $45,000. Finally, Legal & General Group Plc bought a new position in shares of Heartflow in the third quarter worth $59,000.

Heartflow Trading Up 3.2%

Shares of Heartflow stock opened at $25.83 on Friday. The business’s fifty day simple moving average is $29.11 and its 200 day simple moving average is $28.12. The firm has a market capitalization of $2.23 billion and a P/E ratio of -8.31. Heartflow has a 12 month low of $20.13 and a 12 month high of $41.22.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings data on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. The business had revenue of $52.59 million during the quarter. The firm’s quarterly revenue was up 41.3% on a year-over-year basis. Analysts predict that Heartflow will post -0.82 EPS for the current fiscal year.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.